Prof. Xing Zhang, Professor, Chief Physician, and Doctoral Supervisor, serves as Director of the Melanoma and Sarcoma Medical Oncology Unit/Biotherapy Center at Sun Yat-sen University Cancer Center. Recognized as an Outstanding Young Medical Talent of Guangdong Province and a National Distinguished Physician (Exemplary Role Model), she holds key leadership roles including Chair of the Chemoradiotherapy Group under the Sarcoma Committee of Chinese Anti-Cancer Association and Chair of the Sarcoma Committee of Guangdong Clinical Medicine Society. Her pioneering research focuses on immunotherapy and molecular targeted therapy, particularly in genomic profiling, biomarker discovery, and innovative therapy development for sarcomas. As Principal Investigator, she has led over 10 landmark clinical trials, including the first-in-human MDM2 inhibitor clinical trial for sarcomas in China and the groundbreaking TCR-T cell therapy trial for solid tumors. As a prolific scholar, she has authored high-impact publications in journals such as Molecular Cancer, British Journal of Cancer, and Clinical Cancer Research, and spearheaded authoritative works including “Diagnosis and Treatment of Soft Tissue Sarcomas” and the “Chinese Expert Consensus on Medical Therapy for Soft Tissue Sarcomas.“